You just read:

Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option

News provided by

Achieve Life Sciences, Inc.

Dec 19, 2019, 16:05 ET